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S U M M A R Y
Objectives: To evaluate the emergence of New Delhi metallo-b-lactamase 1 (NDM-1)-producing
Enterobacteriaceae isolates in Brazil.
Methods: From April to October 2013, following the detection of the ﬁrst NDM-1-producing isolate, a
surveillance study was performed for the detection of blaNDM-1 among Enterobacteriaceae isolates with
reduced susceptibility to carbapenems in 17 hospitals of Porto Alegre, Brazil. Real-time PCR was used to
determine the presence of carbapenemase genes, which were further sequenced. Clonal relatedness was
assessed by pulsed-ﬁeld gel electrophoresis (PFGE).
Results: A total of 1134 isolates were evaluated. blaNDM-1 was detected in 11 (0.97%) isolates: nine
Enterobacter cloacae complex (eight belonging to a single clone recovered from two distinct hospitals and
the other strain from a third hospital) and two Morganella morganii (belonging to a single clone recovered
from one hospital). Most isolates presented high-level resistance to carbapenems.
Conclusions: NDM-1-producing Enterobacteriaceae have emerged rapidly in the hospitals of the Brazilian
city where they were ﬁrst detected. The emergence of NDM-1 in Brazil is of great concern, since it is a
severe threat to antimicrobial therapy against Enterobacteriaceae in this country.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Carbapenems have been used for many years as the antibiotics
of last resort for the treatment of nosocomial infections caused by
Enterobacteriaceae. Resistance to these drugs in Enterobacteriaceae
has emerged worldwide, mostly driven by the production of
carbapenemases, particularly Klebsiella pneumoniae carbapene-
mase 2 (KPC-2) and, more recently, New Delhi metallo-b-
lactamase 1 (NDM-1).1 The dissemination of carbapenemase-
producing isolates in many countries is of increasing concern, since* Corresponding author. Tel./fax: +55 51 33598152.
E-mail address: azavascki@hcpa.ufrgs.br (A.P. Zavascki).
http://dx.doi.org/10.1016/j.ijid.2014.01.005
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).the treatment of carbapenem-resistant isolates is extremely
difﬁcult owing to the few options that remain available for clinical
use.1,2
NDM-1 mediated by carbapenemases is the most common class
B carbapenemase in Enterobacteriaceae and has been detected
increasingly in several countries.3 In 2013, the ﬁrst case of NDM-1
in Brazil was reported in a Providencia rettgeri isolate in the city of
Porto Alegre.4 Considering the potential for an outbreak at the
institution where this case was detected, and the possibility that
NDM-1 could also be present in other hospitals, surveillance
cultures were performed in many of the regional institutions for
the detection of this carbapenemase. We report the emergence of
blaNDM-1 in Enterobacteriaceae isolates in hospitals from this region
of Brazil.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Phenotypic characteristics and molecular typing of NDM-1-producing Enterobacteriaceae isolates
Minimum inhibitory concentration (mg/ml) – Etest MHT EDTA
No. Datea Hospital Isolateb Specimen IPM MEM ERT DOR SAM PTZ CRO FEP CIP ATM GEN AMK PMB TGC FOS IPM MEM PFGE
1 Apr 1 E. cloacae
complex
Sink
swab
>32 >32 >32 >32 >256 >256 >32 >256 >32 >256 >256 32 0.125 1.5 192 P P P A
2 Apr 1 E. cloacae
complex
Rectal
swab
>32 >32 >32 >32 >256 >256 >32 >256 4 64 1.5 8 0.75 1.5 768 P P P A
3 Apr 1 E. cloacae
complex
Rectal
swab
>32 >32 >32 >32 >256 >256 >32 >256 >32 >256 >256 12 0.25 6 >1024 P P P A
4 May 1 E. cloacae
complex
Rectal
swab
>32 >32 >32 >32 >256 >256 >32 >256 >32 64 12 12 0.38 2 >1024 P P P A
5 Aug 2 E. cloacae
complex
Urine 12 8 32 8 >256 >256 >32 >256 >32 32 >256 12 0.5 1 >1024 P P P A
6 Aug 3 E. cloacae
complex
CSF 12 32 >32 16 >256 >256 >32 192 >32 32 >256 >256 0.38 0.38 64 P P P B
7 Sept 1 M. morganii Rectal
swab
>32 24 1.5 24 >256 >256 >32 16 >32 3 128 12 >1024 4 >1024 N P P MAc
8 Sept 1 M. morganii Surgical
wound
24 1 0.38 3 >256 32 >32 6 >32 2 96 12 >1024 4 >1024 N P P MAc
9 Sept 2 E. cloacae
complex
Rectal
swab
>32 >32 >32 12 >256 >256 >32 >256 6 >256 64 8 0.38 1 96 N P P A
10 Sept 1 E. cloacae
complex
Rectal
swab
>32 >32 >32 >32 >256 >256 >32 >256 >32 >256 32 6 0.38 1 384 N P P A
11 Oct 1 E. cloacae
complex
Rectal
swab
>32 >32 >32 >32 >256 >256 >32 >256 >32 >256 >256 24 1.5 2 256 N P P A
MHT, modiﬁed Hodge test; EDTA, combined disk with ethylenediaminetetraacetic acid; IPM, imipenem; MEM, meropenem; ERT, ertapenem; DOR, doripenem; SAM, ampicillin–sulbactam; PTZ, piperacillin–tazobactam; CRO,
ceftriaxone; FEP, cefepime; CIP ciproﬂoxacin; ATM, aztreonam; GEN, gentamicin; AMK, amikacin; PMB, polymyxin B; TGC, tigecycline; FOS, fosfomycin; N, negative; P, positive; CSF, cerebrospinal ﬂuid.
a Month of 2013.
b E. cloacae, Enterobacter cloacae; M. morganii, Morganella morganii.
c Clonally identical Morganella morganii.
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From April to October 2013, following the detection of the index
case (P. rettgeri), we investigated the presence of NDM-1
carbapenemase among Enterobacteriaceae isolates with reduced
susceptibility to carbapenems5 recovered from 17 hospitals of Rio
Grande do Sul, the southern-most state of Brazil. All isolates were
recovered from patient clinical or surveillance cultures (rectal
swabs and hospital environment swabs) and were sent to the
Laborato´rio de Pesquisa em Resisteˆncia Bacteriana of the Hospital
de Clı´nicas de Porto Alegre (a reference laboratory for the detection
of bacterial resistance in the region) for the detection of the blaNDM
gene.
The following genes were evaluated by multiplex high-
resolution melting (HRM) real-time PCR, as described previously
by Monteiro et al.:6 blaNDM, blaKPC, blaVIM, blaGES, blaOXA-48, and
blaIMP. Brieﬂy, the DNA was extracted using a rapid method based
on thermal shock and lysis of components other than nucleic acids,
and the RT-PCR was carried out using a MeltDoctor HRM Master
Mix (Applied Biosystems) in a StepOne Real-Time PCR System
instrument (Applied Biosystems). Gene sequencing was performed
and GenBank was used to access the blaNDM sequences deposited to
date. BioEdit software was used to compare the similarity between
sequences.
The isolates in which the presence of the blaNDM gene was
conﬁrmed were also submitted to the modiﬁed Hodge test (MHT)
and combined disk tests with ethylenediaminetetraacetic acid
(EDTA).5,7 The minimum inhibitory concentrations (MIC) were
determined by Etest in blaNDM-positive isolates.
Clonal relatedness among NDM-1-producers was assessed by
DNA macrorestriction using XBaI followed by pulsed-ﬁeld gel
electrophoresis (PFGE), and was analyzed according to the criteria
of Tenover et al.8
3. Results
A total of 1134 isolates were analyzed. The presence of blaNDM
was conﬁrmed in 11 (0.97%) Enterobacteriaceae isolates from three
distinct hospitals (all in Porto Alegre city), and sequencing revealed
the presence of blaNDM-1 in all isolates. No patient with an NDM-1-
producing isolate had visited or had been hospitalized in a foreign
country. The phenotypic and molecular characterization of the
isolates is shown in Table 1.
4. Discussion
We detected the presence of blaNDM-1 in Enterobacter cloacae
complex and Morganella morganii isolates, two species different to
the one ﬁrst reported. Six of the nine NDM-producing E. cloacae
complex isolates were recovered from the same institution where
the index P. rettgeri (the ﬁrst case in Brazil) was detected. All six of
these isolates presented an indistinguishable macrorestriction
proﬁle, which was also the same as that of the other two isolates
recovered from another hospital, providing evidence of an initial
horizontal dissemination of one strain among hospitalized patients
of distinct institutions in Porto Alegre. The other E. cloacae complex
isolate, obtained from a third institution in this city, was clonally
unrelated to the major strain. Among all E. cloacae complex
isolates, a similar susceptibility proﬁle was observed against b-
lactams drugs, demonstrating high-level resistance; however, a
distinct proﬁle was found for other non-b-lactam antimicrobial
agents, including aminoglycosides and tigecycline.
It is of note that NDM-1 was mainly detected in Enterobacter
cloacae complex, which comprised only 11.3% of the isolates
evaluated. In fact, worldwide, NDM-1 has mostly been reported in
K. pneumoniae and Escherichia coli, however this gene was notdetected in any isolate of those species, despite the fact that K.
pneumoniae comprised 59.1% of the isolates with reduced
susceptibility to carbapenems (76.6% were KPC-2-producing
isolates; data not shown). Escherichia coli with reduced suscepti-
bility to carbapenems corresponded to only 3.5% of the isolates,
and in 50.0% of the isolates the reduced susceptibility to
carbapenems was due to KPC-2 production (data not shown),
and none to NDM-1.
We also detected blaNDM-1 in two M. morganii isolates, an
organism in which this gene has only rarely been described.9,10 The
potential dissemination of NDM-1-producing M. morganii isolates
is of great concern, since this organism is intrinsically resistant to
polymyxins and tigecycline, which are the agents of last resort
against carbapenemase-producing isolates.
Of note, the combined disk assay with EDTA was able to detect
all NDM-1- producing isolates, reinforcing its sensitivity in the
detection of metallo-b-lactamases. On the other hand, the MHT
failed to detect the presence of carbapenemase activity in isolates
of M. morganii.
In summary, our study demonstrated that following the ﬁrst
detection of an NDM-1-producing Enterobacteriaceae in Brazil,
other NDM-1-producing isolates from two different species have
been detected in a short period of time in distinct institutions.
Considering that KPC-2-producing isolates are highly endemic in
Brazil, our ﬁndings are of major concern, since the emergence of
NDM-1 is a severe threat to antimicrobial therapy against
Enterobacteriaceae in this country.
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